- Business
- Carclo plc Carclo plc engages in the design, development, and manufacture of precision-engineered plastic components and assemblies primarily for the life sciences, aerospace, and advanced technology sectors; its core offerings encompass precision injection molding, multicomponent production, automation, assembly, decoration, and comprehensive supply chain solutions including in vitro diagnostics such as microfluidic devices, pipettes, cuvettes, multiwells, and capillary blood sampling devices, alongside medical devices, drug delivery systems, LED technologies, optics, conductive inkjet technology, and control cables. The company operates through segments including Carclo Technical Plastics and Specialty Division, serving customers in healthcare, diagnostics, automotive, and industrial applications with a global footprint spanning manufacturing and design facilities in the United Kingdom, France, the Czech Republic, China, India, rest of Europe, North America, and the Asia-Pacific region. Founded in 1924 and headquartered in Mitcham, United Kingdom, Carclo plc maintains 13 global locations emphasizing end-to-end services from concept to delivery. Recent developments include a five-year contract renewal with a major customer in July 2025 to strengthen revenue visibility, refinancing arrangements and pension scheme valuation in April 2025, appointment of a new Chief Financial Officer in February 2025, change of registered office in June 2024, bank facilities update in July 2024, temporary share suspension in August 2025 pending 2025 audited results, change of auditor in September 2025, and release of full year 2025 audited results in August 2025 alongside half-year financial report in November 2025.